By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Eisai GmbH 

Lyoner Strasse 36

Frankfurt    D-60528  Germany
Phone: 49-69-66-58-50 Fax: 49-69-66-58-525



Company News
Eisai Company, Ltd. (ESALY.PK) , Abbott Japan To Collaborate To Develop D2E7 Anti-rheumatic Agent Seeking Psoriasis Indication10/19/2005 5:13:16 PM
Eisai Inc. Release: Study Suggests Zonegran(R) (zonisamide) Capsules Are Not Likely To Reduce The Effectiveness Of A Combination Oral Contraceptive10/19/2005 5:13:16 PM
Eisai Company, Ltd. (ESALY.PK) Announces Results Of Osteoporosis Fracture Study Using Menatetrenone10/19/2005 5:12:53 PM
Eisai Inc. Release: First Published Prospective Study Of ARICEPT To Demonstrate Significant Treatment Benefits In Patients Exclusively With Early-Stage Alzheimer's Disease10/19/2005 5:12:27 PM
Eisai Inc. Ensuring That Products - Aricept(R), Aciphex(R) And Zonegran(R) - Remain Available To All Patients10/19/2005 5:12:20 PM
Eisai Company, Ltd. (ESALY.PK) Announces Establishment Of Its Pharmaceuticals Marketing Subsidiary In India10/19/2005 5:12:00 PM
Eisai Inc. And U.S. Pharmacist Honor Pharmacists For Outstanding Service To Patients With Alzheimer's Disease10/19/2005 5:11:58 PM
Eisai Inc. Release: FDA Approves Orally Disintegrating Tablet Formulation Of ARICEPT(R) For The Treatment Of Patients With Mild To Moderate Alzheimer's Disease10/19/2005 5:11:54 PM
Eisai Inc. Release: New Data Suggest Zonegran(R) (Zonisamide Capsules) Reduced Seizure Frequency In Pediatric Epilepsy Patients 10/19/2005 5:11:52 PM
Eisai Company, Ltd. (ESALY.PK) Announces Appointment Of Vice President Of Sales & Marketing 10/19/2005 5:11:46 PM